To select mouse cancer cells before proceeding with the in vivo experiment, we studied the expression of PD-L1 and HMGCR, the target receptors of ATO, in several mouse cancer cell lines, including breast (4T1, EMT6), colorectal (CT26), and lung (LLC1) cancer cells. This evidence concerns the gene HMGCR and cancer.